FindTrial
Sign In

The clinical study to compare and evaluate the effect of madhughrita pratisaran with calcium dobesilate in the management of raktarsha

A randomised comparative clinical trial to evaluate the efficacy of madhughrita pratisaran with calcium dobesilate in management of raktarsha

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031255
Enrollment
60
Registered
2021-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K649- Unspecified hemorrhoids

Interventions

Intervention1: Madhughrita pratisaran: Group A will be treated with Madhughrita pratisaran application for 7 days Control Intervention1: Calcium dobesilate: Group B will be treated with calcium dob

Sponsors

PDEAs college of ayurved and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 20 yrs to 50 yrs Both male and female 1st 2nd 3rd degree hemorrhoides Bleeding piles

Exclusion criteria

Exclusion criteria: Prolapsed of the rectum Perianal abscess Rectal polyp K/c/o fistula in ano K/c/o Crohns disease K/c/o Diverticulitis K/c/o Malignancy K/c/o Hypertension K/c/o Bleeding disorders Hn less than 7gm%

Design outcomes

Primary

MeasureTime frame
To compare the effect of madhughrita pratisaran with calcium dobisilate in 7 days in the management of raktersha on the basis of visual analogus scale and goniometer measurementsTimepoint: difference in bleeding , kleda, grade of piles on 3rd, 5th, 7th day—

Secondary

MeasureTime frame
To study adverse effect if anyTimepoint: difference in bleeding , kleda, grade of piles on 3rd, 5th, 7th day—

Countries

India

Contacts

Public ContactDr nutan sanap

PDEAs college of ayurved and research centre, Nigdi

drbharat_oza@yahoo.co.in9970254593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026